Phase 4 Cardiomyopathy Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
Cardiometabolic Risk FactorsCirrhosisCirrhotic Cardiomyopathy+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh400 enrolled1 locationNCT07322237
Recruiting
Phase 4
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
CardiomyopathySudden Cardiac DeathHeart Failure With Reduced Ejection Fraction (HFrEF)+3 more
University of Rochester2,000 enrolled13 locationsNCT06964464
Recruiting
Phase 4
Use of SGLT2i in noHCM With HFpEF
Hypertrophic CardiomyopathyHeart Failure With Preserved Ejection Fraction
China National Center for Cardiovascular Diseases94 enrolled1 locationNCT06401343
Recruiting
Phase 4
The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
Dilated CardiomyopathyKaposi's Sarcoma-Associated Herpesvirus Infection
Tongji Hospital276 enrolled1 locationNCT06236022